{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:01:39Z","timestamp":1761742899403},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2006,11,1]]},"DOI":"10.1532\/ijh97.06110","type":"journal-article","created":{"date-parts":[[2006,11,20]],"date-time":"2006-11-20T22:45:59Z","timestamp":1164062759000},"page":"343-345","source":"Crossref","is-referenced-by-count":28,"title":["Hyperbaric Oxygen in Addition to Antibiotic Therapy Is Effective for Bisphosphonate-Induced Osteonecrosis of the Jaw in a Patient with Multiple Myeloma"],"prefix":"10.1007","volume":"84","author":[{"given":"Kazuho","family":"Shimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Shimazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonoko","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Horiike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narisato","family":"Kanamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Taniwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med. 2005;353:99-102.","DOI":"10.1056\/NEJM200507073530120"},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Bamias A, Kastritis E, Bamia C, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol. 2005;23:8580-8587.","DOI":"10.1200\/JCO.2005.02.8670"},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Badros A, Weikel D, Salama A, et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol. 2006;24:945-952.","DOI":"10.1200\/JCO.2005.04.2465"},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Ochiai N, Yamada N, Uchida R, et al. Combination therapy with thalidomide, incadronate, and dexamethasone for relapsed or refractory multiple myeloma. Int J Hematol. 2005;82:243-247.","DOI":"10.1532\/IJH97.05049"},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Takahashi R, Shimazaki C, Inaba T, et al. A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells. Leuk Res. 2001;25:77-83.","DOI":"10.1016\/S0145-2126(00)00087-4"},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Vincenzi B, Santini D, Rocci L, Tonini G. Bisphosphonates: new antiangiogenic molecules in cancer treatment? Ann Oncol. 2003;14:806-807.","DOI":"10.1093\/annonc\/mdg194"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Wood J, Bonjean K, Ruetz S, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther. 2002;302:1055-1061.","DOI":"10.1124\/jpet.102.035295"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"McKenzie MR, Wong FL, Epstein JB, Lepawsky M. Hyperbaric oxygen and postradiation osteonecrosis of the mandible. Eur J Cancer B Oral Oncol. 1993;29B:201-207.","DOI":"10.1016\/0964-1955(93)90023-8"},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Epstein J, van der Meij E, McKenzie M, Wong F, Lepawsky M, Stevenson-Moore P. Postradiation osteonecrosis of the mandible: a long-term follow-up study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:657-662.","DOI":"10.1016\/S1079-2104(97)90314-0"},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Berenson JR, Hillner BE, Kyle RA, et al. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol. 2002;20:3719-3736.","DOI":"10.1200\/JCO.2002.06.037"},{"key":"E00011","doi-asserted-by":"crossref","unstructured":"Smith A, Wisloff F, Samson D, et al. Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol. 2006;132:410-451.","DOI":"10.1111\/j.1365-2141.2005.05867.x"},{"key":"E00012","doi-asserted-by":"crossref","unstructured":"Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115-1117.","DOI":"10.1016\/S0278-2391(03)00720-1"},{"key":"E00013","doi-asserted-by":"crossref","unstructured":"Migliorati CA. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol. 2003;21:4253-4254.","DOI":"10.1200\/JCO.2003.99.132"},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004;62:527-534.","DOI":"10.1016\/j.joms.2004.02.004"},{"key":"E00015","doi-asserted-by":"crossref","unstructured":"Greenberg MS. Intravenous bisphosphonates and osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radol Endod. 2004;98:259-260.","DOI":"10.1016\/j.tripleo.2004.08.001"},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer. 2005;104;83-93.","DOI":"10.1002\/cncr.21130"}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.06110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T11:57:52Z","timestamp":1555934272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.06110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,1]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,11,1]]}},"alternative-id":["D3PR1H8794U61776"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.06110","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11,1]]}}}